FdaApplication
NDA 208271
Identifiers
- fda_app_no: NDA208271
Properties
| Property | Value |
|---|---|
| applicant_name | SALIX PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2016-07-19 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RELISTOR | METHYLNALTREXONE BROMIDE | 150MG | TABLET;ORAL |
1 product